- Global Pharma News & Resources

Weekly Life Science News Round Up: 25th – 29th April

A round-up of the latest news from the Life Science industry; including Cell Therapy, Drug Discovery, Clinical Research, Pharmaceutical Manufacturing and more news from 25th – 29th April.


AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

AstraZeneca announces plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub.


Takeda recognized as 2022 ISPE Facility of the Year Awards winner in two categories

Takeda announces that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for the 2022 Facility of the Year Awards (FOYA).


Abbott, CamDiab and Ypsomed unveil new automated insulin delivery partnership for people with diabetes

Abbott, CamDiab and Ypsomed announce that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes.


Exogene raises $2 million for its AI platform to discover cell therapies for cancer

Exogene announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.


Microbiologics acquires Cryologics

Microbiologics announces the acquisition of Cryologics, a leader in cryopreservation of environmental isolates for use as quality control microorganisms.


Pano Therapeutics, Inc. announces the strategic acquisition of NovaTarg Therapeutics, Inc. and the appointment of Ken Batchelor, PhD, as Head of Research & Development

Pano Therapeutics, Inc. announces its strategic acquisition of privately-held NovaTarg Therapeutics, Inc.


ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for gene therapies

ProteoNic and NecstGen announce a partnership for the development of improved viral vector manufacturing for gene therapy applications.


Johnson & Johnson launches next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, focused on antimicrobial resistance (AMR)

Johnson & Johnson announce the launch of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, in Cape Town, South Africa.


Novartis UK announces charity partnerships to support social mobility commitments

Novartis UK has announced new partnerships with local charities to provide volunteering support as part of its annual community partnership day – aimed at improving social mobility across the UK.


Symeres acquires Organix Inc., adding lipids expertise and a strategic foothold in the US

Symeres announces the acquisition of Organix Inc., a US based specialized organic chemistry services provider with a focus on lipids.


Sanofi teams up with McLaren Racing to accelerate industrial excellence

Sanofi announces that it is partnering with McLaren Racing to accelerate manufacturing efficiency and performance in support of the company’s ambition to attain world-class standards of manufacturing excellence.


Innovation partnership with Imperial College Healthcare and Globus Group looks to recycle facemasks into new products for the NHS

Millions of items of PPE discarded in hospitals could be recycled into new products for the NHS like operating theatre clogs, plastic bed pans, medical scrubs and even prosthetic finger joints.


Onyx Scientific opens second site and expands small molecule CMC services

Onyx Scientific, a small molecule API contract development and manufacturing organization, has announced the opening of a second state-of-the-art facility in Sunderland, UK.


Quell Therapeutics and Cellistic™ enter a strategic collaboration to develop an iPSC-derived allogeneic T-regulatory (Treg) cell therapy platform

Quell Therapeutics and Cellistic™ announce that have entered into a strategic collaboration for the co-development of an iPSC-derived Treg cell therapy platform.


EVERSANA announces European expansion with new location in the United Kingdom

EVERSANA™, has opened a new office in the heart of London’s Holborn district to serve the company’s growing client and team needs.


See more of the latest Life Science news on and PharmiWeb.Jobs.

Editor Details

Related Links

Last Updated: 29-Apr-2022